Updating the database of the Illinois Compiled Statutes (ILCS) is an ongoing process.
Recent laws may not yet be included in the ILCS database, but they are found on this site as
Public
Acts soon after they become law. For information concerning the relationship between statutes and Public Acts, refer to the
Guide.
Because the statute database is maintained primarily for legislative drafting purposes,
statutory changes are sometimes included in the statute database before they take effect.
If the source note at the end of a Section of the statutes includes a Public Act that has
not yet taken effect, the version of the law that is currently in effect may have already
been removed from the database and you should refer to that Public Act to see the changes
made to the current law.
(410 ILCS 416/25)
Sec. 25. Reimbursement requirements; notice. (a) A reimbursement under the program at a trial site that conducts clinical trials must: (1) be reviewed and approved by the institutional |
| review board associated with the clinical trial for which the reimbursement is provided; and
|
|
(2) comply with applicable federal and State laws.
(b) The independent third-party organization operating the program is not required to obtain approval from an institutional review board with respect to the financial eligibility of a subject who is medically eligible for a clinical trial.
(c) The independent third-party organization operating the program shall provide written notice to a subject on:
(1) the nature, availability, and scope of the
|
| ancillary financial support under the program; and
|
|
(2) the program's general guidelines on financial
|
|
(Source: P.A. 103-227, eff. 6-30-23.)
|